(Press-News.org) Fast Facts:
More than 30,000 people in the U.S. are diagnosed with Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS).
Johns Hopkins researchers have transformed skin cells donated by ALS patients into brain cells affected by the progressive, fatal disease.
The resulting cell library is being used by researchers worldwide in the quest for better ALS treatments.
Researchers at Johns Hopkins Medicine have transformed skin cells from patients with Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), into brain cells affected by the progressive, fatal disease and deposited those human-made cells into the first public ALS cell library, enabling scientists to better study the disease.
Using a genetic engineering technique that causes adult skin cells to transform into "pluripotent" cells, otherwise known as induced pluripotent stem cells, which can take the form of many different cells found in other parts of the body, "we make brain cells out of the patient's own skin," says Jeffrey Rothstein, M.D., Ph.D., who directs the Brain Science Institute and the Robert Packard Center for ALS Research.
While the technique for creating these human-made cells has been used by other researchers, Rothstein and his colleagues are the first to use these induced pluripotent stem cells to create the largest library of brain cell lines donated voluntarily by more than 20 ALS patients whose disease was caused by various genetic mutations. "These human cellular tools will serve as a platform to understand ALS and someday discover new drugs to treat our patients," says Rothstein, senior author of a study about the work, which was recently published online in PLOS ONE.
More than 30,000 people in the U.S. are diagnosed with ALS. Men appear to be affected slightly more than women. One of every 500 deaths in men is due to ALS, says Rothstein, "so just about everyone is going to know a neighbor, friend or family member who will eventually succumb to this terrible disease."
There is no known cure for ALS and only one FDA-approved drug, riluzole, which may only add a year to a patient's life span, says Rothstein.
Since the 1990s, researchers have studied the disease and its potential treatments in mice. The mouse model looks very much like what happens in people, Rothstein says, "but after 25 years, it has not led to the development of a drug that works in our patients." A handful of drugs were effective in mice and passed phase II clinical trials, which establish a drug's safe dosage for humans, but they all failed phase III trials, which confirm a drug's effectiveness in people.
"There has to be a sea change in how we approach ALS," Rothstein says.
Because there is no ethical or simple way to obtain brain tissue from living ALS patients, Rothstein and colleagues turned to induced pluripotent stem cell production. The technique gives researchers a tool to look at diseased human brain cells, including specialized nerve cells called astroglia, which play a critical role in ALS progression. Rothstein and his team created 22 patient-specific cell lines that included some common mutations known to be associated with ALS and deposited them in a cell library, to be shared with other scientists.
The library includes cells from patients with inherited ALS, which accounts for about 10 percent of ALS cases. Rothstein and his team also have generated cells from patients with the noninherited form of the disease -- sporadic ALS, which makes up 90 to 95 percent of ALS cases. From one patient, the researchers collected a genetic variant found in both inherited and sporadic forms of the disease, and they added that variant to the library.
Many scientists around the world have already used the library, and Rothstein hopes it will grow, with researchers making deposits of their own patients' cell lines. Eventually, induced pluripotent stem cells may be used to model diseases other than ALS and to test potential drug treatments, says Rothstein, who adds: "Now we have a real model for what's wrong with my patients."
INFORMATION:
Ying Li, Devon Cohen, Ping-Wu Zhang, Elizabeth Mosmiller, Nicholas Maragakis and Rita Sattler of Johns Hopkins contributed to the research. The study was supported by grants from the National Institutes of Health, Johns Hopkins, Emerald Foundation, ALS Association and the U.S. Department of Defense. Overall, the development of the library was initiated through the American Recovery and Reinvestment Act (2009). The cell lines are freely available to all researchers via the public warehouse maintained by the Coriell Institute.
The World Health Organization (WHO) have announced a new statement on the public disclosure of clinical trial results which updates and expands a previous statement that noted the "the registration of all interventional trials is a scientific, ethical, and moral responsibility." The new statement includes timelines by which researchers are expected to report clinical trials results. In an Essay published in this week's PLOS Medicine Vasee Moorthy and colleagues from the WHO outline the rationale behind the new statement.
A new element in the WHO statement is the definition ...
Extreme hazards - rare, high-impact events - pose a serious and underestimated threat to humanity. The extremes of the broad ensemble of natural and anthropogenic hazards can lead to global disasters and catastrophes. Because they are rare and modern society lacks experience with them, they tend to be ignored in disaster risk management. While the probabilities of most natural hazards do not change much over time, the sensitivity of the built environment and the vulnerability of the embedded socio-economic fabric have increased rapidly. Exposure to geohazards has increased ...
April 14, 2015 A new material developed at the University of Colorado Boulder could radically reduce the energy needed to produce a wide variety of plastic products, from grocery bags and cling wrap to replacement hips and bulletproof vests.
Approximately 80 million metric tons of polyethylene is produced globally each year, making it the most common plastic in the world. An essential building block for manufacturing polyethylene is ethylene, which must be separated from a nearly identical chemical, ethane, before it can be captured and used.
The similarities between ...
Researchers from the RIKEN Center for Emergent Matter Science in Japan have uncovered the first evidence of an unusual quantum phenomenon--the integer quantum Hall effect--in a new type of film, called a 3D topological insulator. In doing this, they demonstrated that "surface Dirac states"--a particular form of massless electrons--are quantized in these materials, meaning that they only take on certain discrete values. These discoveries could help move science forward toward the goal of dissipationless electronics--electronic devices that can operate without producing the ...
SAN DIEGO (April 14, 2015) -- A team of biologists from San Diego State University has developed a platform for identifying drugs that could prove to be effective against a variety of viral diseases. In a pair of recent articles in the Journal of Biomolecular Screening and the Journal of Visualized Experiments, the researchers describe how the methodology works, using dengue virus as an example, and they identify a novel drug which may someday be used to combat the disease.
Over the past several years, the researchers, led by SDSU biologist Roland Wolkowicz, have been ...
Research from The University of Manchester using cutting edge computer analysis reveals that despite mutating, Ebola hasn't evolved to become deadlier since the first outbreak 40 years ago.
The surprising results demonstrate that whilst a high number of genetic changes have been recorded in the virus, it hasn't changed at a functional level to become more or less virulent.
The findings, published in the journal Virology, demonstrate that the much higher death toll during the current outbreak, with the figure at nearly 10,500, isn't due to mutations/evolution making ...
Physicists from ITMO University, Ioffe Institute and Australian National University managed to make homogenous cylindrical objects completely invisible in the microwave range. Contrary to the now prevailing notion of invisibility that relies on metamaterial coatings, the scientists achieved the result using a homogenous object without any additional coating layers. The method is based on a new understanding of electromagnetic wave scattering. The results of the study were published in Scientific Reports.
The scientists studied light scattering from a glass cylinder filled ...
The number of children being diagnosed with type 1 diabetes is increasing 3-4% every year and more so in school-aged children. Treating the condition is complex and poor management can often lead to medical emergencies that result in hospitalisation, placing ever greater demands on health services.
To improve the efficiency of these services and reduce potentially unnecessary admissions, researchers wanted find out how often children with type 1 diabetes are admitted to hospital compared with children of the same age, gender and socioeconomic class, living in the same ...
The amount of government money pumped into dementia and stroke research in the UK has risen significantly in recent years, but it is still way too low when compared with the economic and personal impact these conditions have, finds a study published in the online journal BMJ Open.
The researchers assessed central government and charity research expenditure in 2012 into the UK's leading causes of death and disability: cancer, coronary heart disease, dementia and stroke.
In 2012, all four conditions accounted for over half (55%) of all UK deaths and for 5.5 million disability ...
Children with type 1diabetes run almost five times the risk of being admitted to hospital for any reason as their peers, finds research published in the online journal BMJ Open.
Pre-schoolers and those from disadvantaged backgrounds are most at risk, the findings indicate.
The number of new cases of childhood type 1 diabetes has been rising steadily by around 3-4% a year, the evidence shows, and the risk of death among those with the condition under the age of 30 is nine times that of the general public.
The researchers analysed the causes of hospital admission after ...
